Pharmacokinetic Study and Toxicity of Leukovir: A New Combined Drug for the Treatment of Multiple Sclerosis

Journals Menu

Follow SCIRP

ISSN Print: 2162-2183
ISSN Online: 2162-2191
www.scirp.org/journal/abc
E-mail: abc@scirp.org

"Pharmacokinetic Study and Toxicity of Leukovir: A New Combined Drug for the Treatment of Multiple Sclerosis"
written by Elena N. Kalinichenko, Irina V. Ponteleeva, Marina B. Golubeva,
published by Advances in Biological Chemistry, Vol.12 No.1, 2022

has been cited by the following article(s):

No relevant information.

Follow SCIRP

[1]	The Development of the Combination Drug Leukovir® Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review Current Drug Targets, 2023 DOI:10.2174/0113894501272301231124074141